New Survey Reveals Only 33% of Americans Worry About Skin Cancer
Results from a new American Academy of Dermatology survey indicate that despite skin cancer being the most widespread cancer in the United States, only an estimated 33% of adults are concerned about developing the disease even though approximately 70% indicate they have at
least one risk factor for it. Read more.

Study Explores the Use of OTC Skin Products in Augmenting Rosacea Treatment
A recently published review investigated the role of skin-barrier impairment in rosacea and reduced symptomatology in patients when they used OTC skincare products. In the publication in the Journal of Drugs in Dermatology, dermatologists participated in a webinar to discuss evidence of barrier dysfunction in rosacea, the role of OTC skincare products in rosacea therapy, and optimal therapeutic regimens to treat the disease. Read more.

FDA Approves StrataGraft for Treating Thermal Burns in Adults
Thermal burns are typically caused by direct contact with a heat source, such as steam, scalding water, hot surfaces, or fire. Recently, the FDA approved a new therapy for these types of burns that is produced from human keratinocytes and dermal fibroblasts, which grown together to
make a bilayered construct. This approved therapy can help prevent or reduce the amount of healthy skin necessary for grafting. Read more.